IPO of condom maker "Mankind Pharma" is coming soon, more than 4 crore equity shares will be sold
Mankind Pharma IPO: IPO of condom maker "Mankind Pharma" is coming soon. More than 4 crore equity shares will be sold in this IPO, through which about Rs 70 crore can be raised.
Mankind Pharma, the maker of popular home pregnancy test kit Prega News and best-selling condom brand 'Manforce', has filed a draft with SEBI (Securities and Exchange Board of India) for an IPO. According to media reports, out of the shares held by the promoters of the company, more than four crores (40,058,884) equity shares will be sold by OFS. Presently the promoters of the company are Ramesh Juneja, Rajiv Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajiv Juneja Family Trust and Prem Sheetal Family Trust.
Established in the year 1991, Mankind Pharma is one of the leading pharmaceutical companies in India, engaged in the manufacture and marketing of a number of products in the pharmaceutical formulation category in health products.
Mankind Pharma is an Indian multinational pharmaceutical company that manufactures drugs ranging from antibiotics to gastrointestinal, cardiovascular, dermal and erectile dysfunction drugs. It focuses on its business in the domestic market (Indian market).
According to the information received, Mankind Pharma Company has made a net profit of Rs 1,084.37 crore in the year 2021 financial year. At the same time, a year ago there was a net profit of Rs 958.23 crore. In the same year, Mankind Pharma launched Critical Care and Savior Mankind, through which life-saving injections are made. In February, Mankind Pharma entered into an agreement with Dr. Reddy's Laboratories Ltd to acquire two brands, Combihale and Daffy.